isatuximab
Compared With Standard Multiple Myeloma Therapy, Isatuximab Doubles Odds of MRD Negativity
In transplant-eligible patients with newly diagnosed multiple myeloma (MM), the novel anti-CD38 monoclonal antibody ...
FEBRUARY 23, 2024

Load more